Skip to main content

Marker of increased cancer risk in benign breast disease

Introduction

Transforming growth factor beta (TGF-β) inhibits the division of mammary epithelial cells, and loss ofreponse to TGF-β is a common event in tumor progression. Previous studieshave shown that the TGF-β-RII receptor is important in cell regulation byTGF-β. Breast epithelial hyperplastic lesions lacking atypia (EHLA) areassociated with increased breast cancer risk.

Aims

To investigate the expression of TGF-β-RII in EHLA and the risk of breast cancer.

Comments

Preliminary data that requires further confirmation. Of note, largeconfidence intervals were found in this study. If confirmed, TGF-β-RIIexpression may help in differentiating large numbers of women with benignbreast disease who are at increased risk of breast cancer and who maybenefit from chemopreventative intervention.

Methods

A nested case-control study of women from the Nashville Breast Study Cohort was coducted.Biopsy-confirmed EHLA with no history of breast cancer or atypicalhyperplasia who subsequently developed breast cancer (n= 54) were comparedwith controls with EHLA who did not develop breast cancer (n=115). Archivalparaffin-embedded breast biopsy specimens were analyzed byimmunohistochemistry with antibodies against TGF-β- RII.

Results

Women with EHLA and 25%-75% TGF-ß-RII positive cells or <25%TGF-β-RII positive cells had a 1.98-fold (95% CI = 0.95-4.1) and a3.41-fold (95% CI = 1.2-10) increased risk of subsequent breast cancer comparedto women in whom 75% of lesion cells were TGF-β-RII positive.

Discussion

Breast cancer risk was inversely correlated with proportion of cellsexpressing TGF-β-RII. These results, in combination with known histologicand epidemiologic risk factors, may better define the clinical manangement ofwomen with proliferative breast disease.

References

  1. 1.

    Chang Jenny , Dupont WD, Simpson JF, Plummer WD, Schuyler PA, Olson SJ, Arteaga CL, Page D: Transforming growth factor-β and breast cancer risk in women with mammary epithelial hyperplasia. J Natl Cancer Inst. 2000, 91: 2096-2101.

    Google Scholar 

Download references

Authors

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Chang, J. Marker of increased cancer risk in benign breast disease. Breast Cancer Res 3, 66706 (2000). https://doi.org/10.1186/bcr-2000-66706

Download citation

Keywords

  • Benign breast disease
  • increased cancer risk
  • TGF-β